Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 64, Issue 1, 1996, Pages 91-100

  Yu, Min ^a   Nishiyama, Akiko ^a   Trapp, Bruce D ^a   Tuohy, Vincent K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cytokine treatment; Demyelination; Experimental autoimmune encephalomyelitis; Interferon ; Multiple sclerosis; Myelin proteolipid protein

Indexed keywords

BETA INTERFERON;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029670711     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-5728(95)00160-3     Document Type: Article

References (29)

1. Abreu, S.L. (1982) Suppression of experimental allergic encephalomyelitis by interferon. Immunol. Commun. 11, 1-7.
2. Abreu, S.L. (1985) Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogenous interferon on the anti-gen-enhanced adoptive transfer of EAE. Int. Arch. Allergy Appl. Immun. 76, 302-307.
3. Abreu, S.L., Tondreau, J., Levine, S. and Sowinski, R. (1983) Inhibition of passive localized experimental allergic encephalomyelitis by interferon. Int. Arch. Allergy Appl. Immun. 72, 30-33.
4. Adams, J.M. and Imagawa, D.T. (1962) Measles antibodies in multiple sclerosis. Proc. Soc. Exp. Biol. Med. III, 562-566.
5. Allen, I. and Brankin, B. (1993) Pathogenesis of multiple sclerosis - the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 52, 95-105.
6. Anderson, J.R. (1988) Viral encephalitis and its pathology. Curr. Topics Pathol. 76, 23-60.
7. Borden, B.C. (1992) Interferons: pleiotropic cellular modulators. Clin. Immunol. Immunopathol. 62, S18-S24.
8. Carlin, J.M., Borden, E.C., Sardel, P.M. and Byrne, G.I. (1987) Biologic response modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J. Immunol. 139, 2424-2428.
9. Carlin, J.M., Borden, E.C. and Byrne, G.I. (1989) Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta ser. J. Interferon Res. 9, 167-173.
10. Ellison, G.W., Visscher, B.R., Graves, M.C. and Fahey, J.L. (1984) Multiple sclerosis. Ann. Intern. Med. 101, 514-526.
11. Farrar, M.A. and Schreiber, R.D. (1993) The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571-611.
12. Gresser, I., Guy-Grand, D., Maury, C. and Maunoury, M.T. (1981) Interferon induces peripheral lymphadenopathy in mice. J. Immunol. 127, 1569-1575.
13. Interferon-β Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
14. Interferon-β Multiple Sclerosis Study Group (1994) Treatment of MS with interferon beta-1b. Final clinical results of the Betaseron trial. J. Neuroimmunol. 54, 178 (abstract).
15. Jacobs, L., Cookfair, D., Rudick, R., Hemdon, R., Riehen, J., Salazar, A., Fischer, J., Granger, C., Simon, J., Goodkin, D. and the Multiple Sclerosis Collaborative Research Group (1994) Results of a phase III trial of intramuscular recombinant beta interferon as treatment for multiple sclerosis. Ann. Neurol. 36, 259 (abstract).
16. Jiang, H., Milo. R., Yong, V.W., Swoveland, P., Johnson, K.P., Panitch, H. and Dhib-Jalbut, S. (1994) Interferon-β reduces antigen presentation in human cells. J. Neuroimmunol. 54, 160 (abstract #P 12.02).
17. Kronenberg, L.H. (1977) Interferon production by individual cells in culture. Virology 76, 634.
18. Kurtzke, J.F. (1993) Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6, 382-427.
19. Lehmann, P.V., Forsthuber, T., Miller, A. and Sercarz, E.E. (1992) Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155-157.
20. Lehmann, P.V., Sercarz, E.E., Forsthuber, T., Dayan, C.M. and Gammon, G. (1993) Determinant spreading and the dynamics of the autoim-mune T-cell repertoire. Immunol. Today 14, 203-208.
21. Ling, P.D., Warren, M.K. and Vogel, S.N. (1985) Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of la antigen in murine macrophages. J. Immunol. 135, 1857-1863.
22. Lisak, R.P. (1980) Multiple sclerosis: evidence for immunopathogenesis. Neurology 30, 99-105.
23. McFarlin, D.E. and McFarland, H.F. (1982) Multiple sclerosis (first of two parts). N. Engl. J. Med. 307, 1183-1188.
24. McRae, B.L., Kennedy, M.K., Tan, L.J., Dal Canto, M.C., Picha, K.S. and Miller, S.D. (1992) Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38, 229-240.
25. Miller, A., Lanir, N., Revel, M., Honigman, S., Kinarty, A. and Lahat, N. (1994) Immunoregulatory effects of recombinant human interferon-β (IFN-β) on human microvessel endothelial cells. Interactions with IFN-γ. J. Neuroimmunol. 54, 182 (abstract #P16.03).
26. Noronha, A., Toscas, A. and Jensen, M. (1993) Interferon β decreases T cell activation and interferon γ production in multiple sclerosis. J. Neuroimmunol. 46, 145-154.
27. Norrby, E., Link, H., Olsson, J., Panelius, M., Salmi, A. and Vandvik, B. (1994) Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect. Immun. 10, 688-694.
28. Panitch, H.S., Hirsch, R.L., Schindler, J. and Johnson, K.P. (1987) Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37, 1097-1102.
29. Paty, D.W. and Li, D.K. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNβ Multiple Sclerosis Study Group. Neurology 43, 662-667.